NCT00653276View on ClinicalTrials.gov

MD Ezetimibe Cyclosporine Interaction (0653-057)

PHASE1CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions

Cholesterol

Interventions

DRUG

ezetimibe

ezetimibe 20 mg (2 x 10 mg tablets) on Days 1 through Day 7.

DRUG

Comparator: cyclosporine

single oral dose of cyclosporine 100 mg capsules on Day 1 or Day 7.

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

Organon and Co

INDUSTRY

NCT00653276 - MD Ezetimibe Cyclosporine Interaction (0653-057) | Biotech Hunter | Biotech Hunter